Shanghai INT Medical Instruments Co

Shanghai INT Medical Instruments Co Revenue

The The revenue of Shanghai INT Medical Instruments Co (1501.HK) as of Nov 10, 2026 is 1.24 B CNY. In the previous year, The revenue was 851.95 M CNY — a change of 45.64% (higher).

Revenue

1.24 BCNY

YoY

45.64%

Last updated:

In 2025, Shanghai INT Medical Instruments Co's sales reached 1.24 B CNY, a 45.64% difference from the 851.95 M CNY sales recorded in the previous year.

Over the last 9 years Shanghai INT Medical Instruments Co grew revenue by 31.2% annually, reaching 1.22 B CNY.

The Shanghai INT Medical Instruments Co Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
Date
Revenue
Jan 1, 2021
541.12 M CNY
Jan 1, 2022
682.27 M CNY
Jan 1, 2023
752.84 M CNY
Jan 1, 2024
851.95 M CNY
Jan 1, 2025
1.24 B CNY
Jan 1, 2026 (e)
1.29 B CNY
Jan 1, 2027 (e)
1.47 B CNY
Jan 1, 2028 (e)
1.67 B CNY
The Shanghai INT Medical Instruments Co Revenue history
YEARRevenueYoY
est1.67 BCNY+12.92%
est1.47 BCNY+14.12%
est1.29 BCNY+4.14%
1.24 BCNY+45.64%
851.95 MCNY+13.17%
752.84 MCNY+10.34%
682.27 MCNY+26.08%
541.12 MCNY+50.97%
358.43 MCNY+25.12%
286.46 MCNY+41.07%
203.06 MCNY+47.62%
137.55 MCNY+29.22%
106.45 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shanghai INT Medical Instruments Co Revenue

Shanghai INT Medical Instruments Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
540.38 M CNY
182.04 M CNY
166.48 M CNY
Jan 1, 2022
695.98 M CNY
169.19 M CNY
153.38 M CNY
Jan 1, 2023
758.28 M CNY
178.32 M CNY
156.46 M CNY
Jan 1, 2024
855.81 M CNY
216.21 M CNY
191.91 M CNY
Jan 1, 2025
1.22 B CNY
316.11 M CNY
254.78 M CNY
Jan 1, 2026 (e)
1.29 B CNY
288.57 M CNY
309.65 M CNY
Jan 1, 2027 (e)
1.47 B CNY
329.21 M CNY
354.20 M CNY
Jan 1, 2028 (e)
1.67 B CNY
419.89 M CNY
0.00 CNY

Shanghai INT Medical Instruments Co Margins

Shanghai INT Medical Instruments Co stock margins

The Shanghai INT Medical Instruments Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Shanghai INT Medical Instruments Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Shanghai INT Medical Instruments Co.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
59.42 %
33.69 %
30.81 %
Jan 1, 2022
55.63 %
24.31 %
22.04 %
Jan 1, 2023
57.77 %
23.52 %
20.63 %
Jan 1, 2024
62.83 %
25.26 %
22.42 %
Jan 1, 2025
60.54 %
25.81 %
20.80 %
Jan 1, 2026 (e)
60.54 %
22.33 %
23.96 %
Jan 1, 2027 (e)
60.54 %
22.33 %
24.02 %
Jan 1, 2028 (e)
60.54 %
25.22 %
0.00 %

Shanghai INT Medical Instruments Co Stock analysis

What does Shanghai INT Medical Instruments Co do? Shanghai Kindly Medical Instruments Co., Ltd. generates revenue through the research and development, manufacturing, and sales of interventional and implantable medical devices. The company's cardiovascular intervention business focuses on cardiovascular interventional medical devices, related molds, and accessories, with main products including inflation device, Introducer set, and guidewire. It serves domestic and overseas markets such as Europe and the United States, targeting healthcare providers and medical institutions that require specialized equipment for minimally invasive procedures. The firm expands its product portfolio beyond cardiovascular devices to include neurological interventional medical devices and endocardia implantable medical devices, catering to diverse clinical needs. Its domestic market presence is complemented by exports to Europe and the United States, where it supplies hospitals and clinics seeking high-quality medical devices for patient care. The company's full-time workforce of 1,532 employees supports these operations, ensuring consistent production and delivery of its medical device solutions. Shanghai Kindly Medical Instruments Co., Ltd. operates with a clear focus on interventional and implantable medical devices, leveraging its R&D capabilities to develop specialized products. Its business model relies on direct sales of these devices to healthcare facilities, with no mention of third-party partnerships or additional revenue streams beyond the core product lines described. Shanghai INT Medical Instruments Co is one of the most popular companies on Eulerpool.

Revenue Details

Understanding Shanghai INT Medical Instruments Co's Sales Figures

The sales figures of Shanghai INT Medical Instruments Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Shanghai INT Medical Instruments Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Shanghai INT Medical Instruments Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Shanghai INT Medical Instruments Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Shanghai INT Medical Instruments Co stock

The revenue of Shanghai INT Medical Instruments Co is 1.24 B CNY in 2025.

The revenue of Shanghai INT Medical Instruments Co changed from 851.95 M CNY to 1.24 B CNY, representing a 45.64% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The revenue Shanghai INT Medical Instruments Co since 2006 – with annual values, charts, and detailed analysis.

Revenue is the total value of all goods sold in a period. It is calculated by multiplying the quantity of each product sold by its selling price. Revenue does not include any costs (material costs, personnel costs, etc.), whereas net proceeds only deduct revenue reductions associated with the sale (discounts, etc.).

The revenue's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The revenue's Shanghai INT Medical Instruments Co historically and in real time.

The revenue in assessing a stock

Revenue is an important financial measure used in the valuation of stocks. It is a measure of a company's economic activity and can serve as an indicator of the company's success. Revenue is considered one of the most important factors in stock valuation. In addition, revenue can also be used to calculate other financial measures such as earnings per share and price-earnings ratio.

History and utilization of revenue

Revenue has long been considered one of the most important financial indicators. It was used in the 19th century as one of the first financial indicators to measure a company's economic activity. Since then, revenue has been regularly used to evaluate companies.

Revenue is usually calculated as a percentage of the company's equity. It can also be used to determine the overall profitability of a company. There are many different types of revenue that can be used to measure a company's economic activity, such as gross revenue, net revenue, and revenue from international business.

The revenue can also be used to evaluate stocks. For example, the revenue of a company can be used to evaluate the success of the company. If a company has high revenue, it means that it is a profitable company because it has high demand for its products or services.

Calculation and Application of Revenue

In order to calculate a company's revenue, the company's income must be deducted from its expenses. The income can come from various sources, such as sales, licensing fees, services, etc. The expenses can include costs for production, procurement, inventory, sales, and administration.

The revenue can then be used to calculate various financial ratios. For example, the revenue can be used to calculate the price-earnings ratio (P/E ratio) of a company. This is a measure of a company's profitability, calculated by taking the ratio of the stock price to earnings per share.

Revenue can also be used to calculate earnings per share (EPS) of a company. This is a measure of a company's profit per share. EPS is calculated by dividing earnings by the number of shares issued.

Use of revenue by investors

Investors use revenue to evaluate stocks, as revenue is an indicator of a company's success. For example, an investor can compare a company's revenue to see how successful it is. An investor can also use a company's revenue to calculate its price-to-earnings ratio and earnings per share.

An example: An investor looks at a company that has a revenue of 25 million euros. He compares this revenue to that of the competitor, which has a revenue of 35 million euros. The investor can then see that the company with 25 million euros in revenue is less successful than the company with 35 million euros in revenue.

Advantages and Disadvantages of Revenue.

Revenue is a very useful tool for valuing stocks as it measures a company's economic activity. Revenue can also be used to calculate other financial ratios such as the price-earnings ratio and earnings per share.

However, one disadvantage is that revenue alone is not a meaningful indicator of a company's success. It is important to consider revenue in comparison to other financial metrics such as earnings per share and price-to-earnings ratio to get a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Shanghai INT Medical Instruments Co

All Key Metrics — Shanghai INT Medical Instruments Co